Introducing alternatives to film-coated tablets! Achieving a reduction in production costs.
The "OSDrC" technology allows for precise and flexible control of the inner core due to its variable double-structure technology, enabling the production of higher quality core tablets than ever before, as well as the development of various new dosage forms. Core tablets with an extremely thin outer layer can also be manufactured in one step. This makes it possible to replace film-coated tablets, significantly compresses the manufacturing process, and reduces production costs. 【Features】 ■ Core tablets with an extremely thin outer layer can be manufactured in one step ■ Enables the replacement of film-coated tablets ■ Significant compression of the manufacturing process ■ Achieves reduction in production costs *For more details about OSDrC technology, please refer to the OSDrC main brochure available on the special website below or feel free to contact us.
Inquire About This Product
basic information
Please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
Please feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Sanwa Chemical Research Institute, as a member of the Suzuken Group focused on health creation, provides services aimed at improving the quality of life (QOL) for people who wish for better health, centered around its two main businesses: "pharmaceuticals" and "diagnostic drugs." In the "pharmaceuticals business," we are steadily building a track record with a focus on new drugs in the areas of diabetes and kidney/dialysis-related fields. In the "diagnostic drugs business," we are continuously developing and launching self-blood glucose meters, sensors, and diagnostic drugs for infectious diseases. Furthermore, by adding two more businesses— the "OSDrC (Osudrack) business" utilizing innovative formulation technology and the "contract manufacturing business" with advanced quality control systems— Sanwa Chemical Research Institute continues to evolve further.